Comparison of questionnaire scores among genotypes for the significant associations. by Dai Nogimura (21445649)

Subjects:

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

BST2 overexpression decreased RSV multiplication. by Katherine Marougka (13015146)

Related inflammation evaluation indexes before and after operation (mean±standard deviation). by Na Wang (193263)

Subjects:

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)

Subjects:

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Animal studies demonstrated that inotodiol possessed the ability to suppress tumor growth in nude mice models, at the same time, there was no significant impact on the body weight and organs of the mice. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

Mean of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

Mean of the difference between the LV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Subjects:

Mean values (± standard deviation) of CK, CK-MB and LDH before and after CWI. by Aneta Teległów (9570190)

Subjects:

Why does task performance decrease with burst length? by Swathi Anil (17382903)

Mean KAP scores and standard deviation at different assessment times. by Chikondi Maluwa (20660522)

Subjects:

High ambient temperatures reduce body fat and alter the expression of genes involved in lipid metabolism. by Tucker Hopkins (20790529)

Subjects:

Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%). by Na Wang (193263)

Subjects:

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects: